We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Encysive, Glaxo Target Barr For Blood Clotting Generic

Law360 (January 4, 2008, 12:00 AM EST) -- Encysive Pharmaceuticals Inc., GlaxoSmithKline and Mitsubishi Chemical Corp. have filed a patent infringement lawsuit to stop Barr Laboratories from producing a generic version of anti-blood clotting Argatroban injections.

The suit was...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.